ERGAGIN
Main information
- Trade name:
- ERGAGIN 5*1ML INJ
- Active ingredient:
- Methylergometrine Maleate
- Available from:
- Mercury
- Dosage:
- 0.2MG
- Pharmaceutical form:
- INJ
- Composition:
- 5*1ML
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
31-8-2018
Human medicines European public assessment report (EPAR): Pixuvri, pixantrone dimaleate, Revision: 18, Authorised
Europe - EMA - European Medicines Agency
1-8-2018
Veterinary medicine European public assessment report (EPAR): Apoquel, oclacitinib maleate, Revision: 4, Authorised
Europe - EMA - European Medicines Agency
30-7-2018
Apoquel (Zoetis Belgium S.A.)
Apoquel (Active substance: Oclacitinib maleate) - Centralised - Renewal - Commission Decision (2018)5153 of Mon, 30 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/2688/R/13
Europe -DG Health and Food Safety